novo nordisk - Search News

News

Novo Nordisk slashes price of Ozempic

ABC News on MSN · 5h

Novo Nordisk slashes price of weight loss drugs

Novo Nordisk is teaming up with GoodRx to offer Wegovey and Ozempic for a flat price of $499 a month. Top Air Force general to exit in Hegseth’s latest shake-up of Pentagon

Fox Business on MSN · 1d

Novo Nordisk to sell weight-loss drug for $499 to eligible customers

Cash-paying type 2 diabetes patients in the United States can now access Novo Nordisk's Ozempic for $499 per month through multiple pharmacy platforms.

NBC10 Philadelphia · 1h

Novo Nordisk slashes price of Ozempic to $499 for cash-paying, uninsured patients

Novo Nordisk is slashing the price of its blockbuster diabetes drug Ozempic for U.S. patients who self-pay or are uninsured.

Novo Nordisk shares pop

Reuters on MSN · 1d

Shares in Novo Nordisk rise after Wegovy gets US nod for liver disease treatment

Shares in Novo Nordisk rose on Monday, after it got U.S. approval for its weight-loss drug Wegovy to treat a serious liver condition, positive news for the drugmaker that lost more than one-third of its market value in recent weeks.

The Wall Street Journal · 1d

FDA Approves Novo Nordisk’s Wegovy for Liver Disease

Novo Nordisk shares climbed after the U.S. Food and Drug Administration approved a new indication for the Danish drugmaker’s blockbuster Wegovy medicine to treat a serious fatty liver disease.

MarketWatch on MSN · 1d

Novo Nordisk shares are rising. The FDA approves another use for Wegovy.

Novo Nordisk shares were climbing Monday after the Food and Drug Administration approved the popular weight-loss drug Wegovy to treat a form of liver disease. The FDA approved Wegovy for use in what’s called noncirrhotic metabolic dysfunction-associated steatohepatitis, or MASH, in adults with moderate to advanced liver fibrosis.

21h

Novo Nordisk: Negative Streak Finally Ended

The string of negative updates from Novo Nordisk and positive news flow from the main competitor Eli Lilly has finally ended ...

1d

Stock Movers: Novo Nordisk, GoodRX, CVS

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

1d

Stocks to Watch Monday: Novo Nordisk, TeraWulf, UnitedHealth, Soho House

The Food and Drug Administration approved Novo Nordisk's popular weight-loss drug Wegovy to treat a form of liver disease.

6hon MSN

Home Depot disappoints, Novo Nordisk's GLP-1 updates, an AI warning and more in Morning Squawk

Home Depot kicked off this week's string of retailer earnings reports. Novo Nordisk provided two major updates on its ...

1d

From Doubt To Action: Why I Bought Novo Nordisk After Earnings

Novo Nordisk A/S innovation and growth continue to shine. Now, it has a partnership with GoodRX Holdings. Click for my ...

1don MSN

GoodRx stock soars after striking deal to sell Novo Nordisk's GLP-1s for $499/month

GoodRx is joining the GLP-1 action with an announcement Monday to begin selling both Novo Nordisk's GLP-1 drugs, Ozempic and ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results